Skip to main content

ProShare Advisors LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 1357955 BETHESDA, MD

Position in ROIV

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,464,119
+$76,294 QoQ
Shares Held
41,371
-17.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#214
of 494 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. ROIV ranks #9 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ROIV

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,464,119 41,371
2026-03-31 $1,387,825 50,102
2025-12-31 $1,047,893 48,290
2025-09-30 $644,931 42,626
2025-06-30 $496,466 44,052
2025-03-31 $505,761 50,125
2024-12-31 $645,728 54,584
2024-09-30 $723,788 62,720
2024-06-30 $650,921 61,582
2024-03-31 $595,235 56,474
2023-12-31 $576,840 51,366
2023-09-30 $589,279 50,452
2023-06-30 $494,655 49,073
2023-03-31 $388,040 52,580
2022-12-31 $479,368 59,996